Stine Marit Moen
- Head of Research and Development and Senior Consultant Neurologist at the MS-Centre Hakadal, Norway; MD, PhD
Stine Marit Moen has a medical doctor degree from the University of Oslo in 1997. She has worked within neurology at Department of Neurology, Innlandet Hospital Lillehammer and 11 years at Department of Neurology at Oslo University Hospital. She defended her PhD degree with the thesis "Multiple sclerosis, bone health, and vitamin D" in 2012 and worked thereafter with special focus on diagnosis, treatment and follow-up of patients with MS. She also held a position from 2015 as Associate Professor in neurology at the Institute of Clinical Medicine, University of Oslo.
Stine Marit Moen entered a new position in fall 2016 as Head of Research and Development at the MS Centre Hakadal, a key national MS rehabilitation centre. The MS-Centre Hakadal is a member of the RIMS (Rehabilitation in MS, European Network for best practice and research) and a member of the Norwegian Brain Council. See their homepage at http://www.mssenteret.no/
Stine Marit Moen is from 2017 member of the Norwegian MS Competence Centre’s Reference Group and from 2016 member of the Norwegian MS Society Advisory Board.
- MS and vitamin D, MS and bone health
- Clinical research and clinical trials in MS
- Clinical neurology, symtomatic treatment and rehabilitation
- A holistic approach to treatment and follow-up of MS
Stine Marit Moen has co-supervised the PhD-students:
Pål Berg-Hansen and his PhD thesis "Clinical and epidemiological studies of immigrants with multiple sclerosis in Norway" (defended 2015).
Cecilia Smith Simonsen and her ongoing PhD project on multiple sclerosis and NEDA: «Predictors for disease susceptibility and disease progression in Multiple sclerosis».
She has also co-supervised medical students in their student projects and bachelor projects.
Highlighted article in Neurology Podcast July 12 2011, Neurology, American Academy of Neurology:https://www.aan.com/rss/search/home/episodedetail/?item=2258
She was the first author in the 2016 published initiative for recommendations on the use of MRI in MS in Norway.
Increased DNA methylation of SLFN12 in CD4+ and CD8+ T cells from multiple sclerosis patients
PLoS One, 13 (10), e0206511
Restriction spectrum imaging of white matter and its relation to neurological disability in multiple sclerosis
Mult Scler, 25 (5), 687-698
Migraine and frequent tension-type headache are not associated with multiple sclerosis in a Norwegian case-control study
Mult Scler J Exp Transl Clin, 2, 2055217316682976
S.M. Moen og medarbeidere svarer
Tidsskr Nor Laegeforen, 136 (19), 1608
S.M. Moen og medarbeidere svarer
Tidsskr Nor Laegeforen, 136 (20), 1702
MRI- investigations in multiple sclerosis
Tidsskr. Nor. Laegeforen., 136 (16), 1373-1376
[MRI in multiple sclerosis]
Tidsskr Nor Laegeforen, 136 (16), 1373-6
Bone mineral density in patients with multiple sclerosis, hereditary ataxia or hereditary spastic paraplegia after at least 10 years of disease - a case control study
BMC Neurol, 16 (1), 252
Comments on the review article 'Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades'
Acta Neurol Scand, 132 (5), 364-7
High prevalence and no latitude gradient of multiple sclerosis in Norway
Mult Scler, 20 (13), 1780-2
Prevalence of multiple sclerosis among immigrants in Norway
Mult Scler, 21 (6), 695-702
No association between multiple sclerosis and periodontitis after adjusting for smoking habits
Eur J Neurol, 22 (3), 588-90
Environmental exposures and the risk of multiple sclerosis investigated in a Norwegian case-control study
BMC Neurol, 14, 196
Bone turnover and metabolism in patients with early multiple sclerosis and prevalent bone mass deficit: a population-based case-control study
PLoS One, 7 (9), e45703
Intrathecal levels of vitamin D and IgG in multiple sclerosis
Acta Neurol Scand, 125 (6), e28-31
Fractures and falls in patients with newly diagnosed clinically isolated syndrome and multiple sclerosis
Acta Neurol Scand Suppl (191), 79-82
Low bone mass in newly diagnosed multiple sclerosis and clinically isolated syndrome
Neurology, 77 (2), 151-7
Vitamin D in the healthy and inflamed central nervous system: access and function
J Neurol Sci, 311 (1-2), 37-43
Assessing vitamin D in the central nervous system
Acta Neurol Scand Suppl (190), 88-92
25-hydroxyvitamin D in cerebrospinal fluid during relapse and remission of multiple sclerosis
Mult Scler, 15 (11), 1280-5